Hormone replacement therapy refers to the treatment of the patients with hormone deficiency due to conditions such as dwarfism or women nearing menopause, which requires replacement of hormones in the body whose levels have become low.



Highlights



The global Drugs For Hormonal Replacement market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.



North American market for Drugs For Hormonal Replacement is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.



Asia-Pacific market for Drugs For Hormonal Replacement is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.



The key global manufacturers of Drugs For Hormonal Replacement include Eli Lilly, Pfizer, AbbVie, Novo Nordisk, Merck KGaA, Mylan, Bayer, Teva and Novartis, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.



Report Scope



This report aims to provide a comprehensive presentation of the global market for Drugs For Hormonal Replacement, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs For Hormonal Replacement.



The Drugs For Hormonal Replacement market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Drugs For Hormonal Replacement market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.



For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.



The report will help the Drugs For Hormonal Replacement manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.




By Company




Eli Lilly



Pfizer



AbbVie



Novo Nordisk



Merck KGaA



Mylan



Bayer



Teva



Novartis



Abbott



Roche



Endo International



Ipsen



ANI Pharmaceuticals



TherapeuticsMD




Segment by Type




Estrogen Hormone



Growth Hormone



Thyroid Hormone



Testosterone Hormone




Segment by Application




Menopause



Hypothyroidism



Growth Hormone Deficiency



Male Hypogonadism



Other Diseases




Consumption by Region




North America



U.S.



Canada



Europe



Germany



France



U.K.



Italy



Russia



Asia-Pacific



China



Japan



South Korea



India



Australia



Taiwan



Indonesia



Thailand



Malaysia



Philippines



Vietnam



Latin America



Mexico



Brazil



Argentina



Middle East & Africa



Turkey



Saudi Arabia



U.A.E



Core Chapters



Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.



Chapter 2: Detailed analysis of Drugs For Hormonal Replacement manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.



Chapter 3: Sales, revenue of Drugs For Hormonal Replacement in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.



Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.



Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.



Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.



Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.



Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.



Chapter 9: The main points and conclusions of the report.